OmniBRx Biotechnologies

OmniBRx Biotechnologies is an Indian origin multinational bioprocess engineering company dedicated to transforming the quality, scalability, and predictability of biologics Mfgr. Our primary focus lies in the design, development, and provision of cutting-edge single-use bioreactor technologies that drive advancements in the field of Biologics viz vaccines | Viral Vectors | Cell and Gene Therapy |mAbs |Recombinant Protein. OmniBRx commitment to innovation is further exemplified by our patented technology: DYNAMIC-BED REACTOR (WO2017158611A1, US20180187139A1, EP3430119A1). These patents testify to our dedication to continuous improvement and top-notch solutions. As a QMS 9001:2015 certified company, OmniBRx adheres to stringent GMP guidelines for operation and management. Which support to deliver superior solutions that not only meet regulatory standards but drive customer success. One of our key strengths is our ability to offer the world’s largest surface area of 1500M2 in a 200L Bioreactor, all within the smallest footprint. This disruptive technology offers exceptional productivity and reduces carbon footprint upto 95%. Overall, it brings down the cost of vaccine and other biological products. Technological advancement that bring significant value to customers in several ways:  Fully Scalable Culture Systems  Single-Use, Closed loop Systems  Accelerated Time to Market  Enhanced Cell Health and Quality  Cost Efficiency and Increased Protein Yield To guarantee the utmost safety and compliance, our single-use bioreactors are biocompatible, USP Class VI, & free from TSE and BSE contamination. We strive to provide the ultimate service experience while maintaining the highest product quality standards. Our efficient and cost-effective disposable systems, coupled with excellent technical services, enable our customers to overcome complex cell culture challenges with confidence.